Dec
2024
The UK Small-Cap Puzzle
DIY Investor
5 December 2024
Introduction
The small-cap premium suggests that small-cap stocks tend to outperform their large-cap counterparts over the long term. Recently, however, this trend has reversed, with large-caps considerably outperforming small-caps across global markets. Interestingly, this year in the United Kingdom, the FTSE Small cap index has marginally outperformed the FTSE 100, suggesting that the small-cap premium may still hold some relevance. This raises several important questions: If the UK is an outlier, are UK small caps worth investing in? Does the composition of small-cap indices limit their ability to fully capture the small-cap premium? And what strategies can investors use to uncover opportunities within this space?
Factor Investing
Factors are persistent, quantifiable drivers of return that systematically influence equity markets. The small-cap factor captures the premium for investing in smaller companies over their large-cap counterparts based solely on market capitalisation. The factor is expected to yield a positive return over the long term, compensating investors for the higher risks associated with smaller companies.
From the start of 2024 to the end of the third quarter, the small-cap factor in developed markets and the U.S. showed a negative return, indicating that small-cap stocks underperformed large-cap stocks in these regions. In contrast, the small-cap factor in the UK demonstrated positive performance, suggesting that the UK may indeed be an outlier. If the UK small-cap premium has performed so strongly, why has the FTSE Small Cap index barely outperformed the FTSE 100?
Index Composition
The FTSE Small Cap index outperformed the FTSE 100 by approximately 1% over this period. Both indices include a diverse range of companies, and their performance can be influenced by many factors beyond just company size, such as industry composition, style tilts, and idiosyncratic effects. For instance, while the FTSE Small Cap’s strong small-cap and value exposure acted as a favourable tailwind, the investment trusts tilt hindered overall performance. Investors may not fully grasp the specific factors they are exposed to when investing via an index tracker.
The FTSE Small Cap index his a significant exposure to investment trusts, which make up over 50% of its constituents. While the FTSE 100 and its ex-investment trust version show similar performance, the FTSE Small Cap index tells a different story. The FTSE Small Cap ex-Investment Trusts index outperforms both the FTSE Small Cap index and the FTSE 100 by 5-6%. Given that investment trusts constitute half of the FTSE Small Cap index, is the index truly representative of small-cap stocks?
% of Investment Trusts in Index | |
FTSE Small Cap | 50.60 |
FTSE 100 | 1.05 |
Pure Small-Cap
To assess whether a tailored small-cap strategy could have enhanced the performance even further, we constructed a rules-based portfolio exclusively of UK small-cap non-investment companies. Our analysis indicates that a strategy focused on capturing the pure small-cap premium and favouring companies trading at attractive valuations could have significantly improved performance relative to the FTSE 100.
This underscores the potential benefits of active management in identifying and capitalising on opportunities within the small-cap space. By leveraging the expertise of seasoned fund managers, investors can not only harness this potential but also capture additional alpha through meticulous stock selection.
From the start of 2024 to the end of the third quarter, JOHCM UK Growth’s small-cap holdings outperformed the FTSE Small Cap ex-Investment Trusts index by more than 9%, while JOHCM UK Equity Income’s holdings outperformed the index by over 5%. With small-cap allocations of 40-50% and 15-20%, respectively, these funds have effectively leveraged this exposure to capture growth opportunities in the UK market. Year-to-date, JOHCM UK Growth is up 18.44% and JOHCM UK Equity Income is up 18.64%, compared to the FTSE All-Share, which is up 7.89% (source: JOHCM/FTSE as at 30 October 2024).
Comments from the Desk
Mark Costar – Senior Fund Manager
JOHCM UK Growth Fund
“The UK small-cap market is awash with exciting growth companies and significant pricing anomalies. That culmination has, and will continue to offer, very substantial opportunities to add alpha for the active manager. JOHCM UK Growth has a significant allocation to this area, many of which have delivered very strong returns, including Funding Circle, Science in Sport, and Eleco. These names still have substantial upside potential, alongside a host of other high quality, structural growth companies in the portfolio, many of which are world leaders in their respective fields.”
James Lowen – Senior Fund Manager
JOHCM UK Equity Income Fund
“This article highlights some interesting points, for example, the fact that around half of the FTSE Small Cap index consists of investment trusts. The latter, which largely represents a significant block of beta, is a key reason why asset allocators should steer away from index trackers in this space and instead focus on active managers. We have consistently generated outperformance from our small-cap allocation. Names such as DFS, Wickes, Eurocell, and Forterra are either market leaders or major players in their respective markets. These businesses are led by strong management teams, are gaining market share and trade at compelling valuations. Based on a reasoned central-case view, many of these stocks have the potential to double in value”.
Conclusion
In summary, the dynamics of small-cap investing have become increasingly nuanced. While our research suggests that the small-cap premium is still relevant in the UK, the composition of small-cap indices limits their ability to fully capture potential returns. This highlights the challenges associated with passive investment strategies, which do not provide a pure small-cap exposure. To navigate these complexities, investors might benefit from considering the role of active management in exploring opportunities within the UK market.
Note: Axioma Size factor is calculated so larger stocks have higher exposures. We have flipped the sign so that small stocks have higher exposures (and therefore called it the Small-Cap factor) for better alignment with our thesis.
Professional investors only.
Issued and approved in the UK by J O Hambro Capital Management Limited (“JOHCML”) which is authorised and regulated by the Financial Conduct Authority. Registered office: Level 3, 1 St James’s Market, London SW1Y 4AH. Perpetual Group is a trading name of JOHCML.
This is a marketing communication. Please refer to the fund prospectus and to the KIID / KID before making any final investment decisions.
These documents are available in English at www.johcm. com, and available from JOHCML at the address set out above.
Information on the rights of investors can be found here.
The distribution of this document in jurisdictions other than those referred to above may be restricted by law (“Restricted Jurisdictions”). Therefore, this document is not intended for distribution in any Restricted Jurisdiction and should not be passed on or copied to any person in such a jurisdiction.
The registrations of the funds described in this document may be terminated by JOHCM at its discretion from time to time.
Notice to investors in Switzerland: The representative of the Company in Switzerland is 1741 Fund Solutions Ltd., Burggraben 16, 9000 St. Gallen, Switzerland (the “Representative”). The paying agent of the Company in Switzerland is Tellco Ltd, Bahnhofstrasse 4, 6430 Schwyz, Switzerland. The Prospectus, the KIDs, the Instrument of Incorporation / the Constitution, and the annual and semi-annual reports may be obtained free of charge from the Representative. The Company is defined as J O Hambro Capital Management UK Umbrella Fund (domiciled in the UK), Perpetual Investment Services Europe ICAV (domiciled in Ireland) or Regnan Umbrella Fund ICAV (domiciled in Ireland), as relevant.”
This fund has not been authorised by the Hong Kong Securities and Futures Commission and no person may issue, or have in its possession for the purposes of issue, whether in Hong Kong or elsewhere, any advertisement, invitation, or document relating to this fund, which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong. This fund is only for offer and sale to persons in Hong Kong who are “professional investors” as defined in the Securities and Futures Ordinance (cap. 571) of Hong Kong and any rules made under that Ordinance. This document and the information contained herein may not be used other than by the person to whom it is addressed and may not be reproduced in any form or transferred to any person in Hong Kong. The contents of this document have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about the contents of this document, you should seek independent professional advice.
This document is only allowed to be distributed to certain relevant persons and not to the retail public in Singapore. The Fund, which is not authorised or recognised by the Monetary Authority of Singapore (the “Authority”), is registered under the Restricted Foreign Scheme with the Authority and the shares in the Fund (“Shares”) are not allowed to be offered to the retail public. Moreover, this document is not a prospectus as defined in the Securities and Futures Act, Chapter 289 of Singapore (the “SFA”). Accordingly, statutory liability under the SFA in relation to the content of prospectuses would not apply. Investors should consider carefully whether the investment is suitable for them. This document and any document or material in connection with the offer or sale, or invitation for subscription or purchase, of Shares may not be circulated or distributed, nor may Shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to the retail public or any member of the retail public in Singapore other than (i) to an institutional investor, and in accordance with the conditions specified, in Section 304 of the SFA; (ii) to an investor falling within the definition of “relevant persons”, and in accordance with the conditions specified, in Section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. Where Shares are acquired under Section 305 of the SFA by a relevant person, investors should note that the first sales and transfers of the Shares are subject to the applicable provisions of the SFA, which include section 305A of the SFA.
The investment promoted concerns the acquisition of shares in a fund and not the underlying assets.
Past performance is no guarantee of future performance. The value of an investment and the income from it can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.
Investments may include shares in small-cap companies and these tend to be traded less frequently and in lower volumes than larger companies making them potentially less liquid and more volatile.
The information contained herein including any expression of opinion is for information purposes only and is given on the understanding that it is not a recommendation.
The information in this document does not constitute, or form part of, any offer to sell or issue, or any solicitation of an offer to purchase or subscribe for any funds or strategies described in this document; nor shall this document, or any part of it, or the fact of its distribution form the basis of, or be relied on, in connection with any contract.
Telephone calls to and from JOHCML may be recorded. Information on how personal data is handled can be found in the JOHCM Privacy Statement on its website: www.johcm.com
J O Hambro® and JOHCM® are registered trademarks of JOHCML.
Sources: JOHCM/MSCI Barra/Bloomberg (unless otherwise stated)
Leave a Reply
You must be logged in to post a comment.